Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Clinical trial NCT00068250 · COMPLETED

Trial details

NCT number: NCT00068250
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Lymphoma

Start date: 2003-07-01
Primary completion: 2016-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.